Healthcare Companies to Face Intensifying Scrutiny of COVID-19 Provider Relief Funds from Government and Whistleblowers
NASHVILLE, Tenn., Feb. 13, 2023 /PRNewswire-PRWeb/ -- In 2022, the federal government set the stage for wider scrutiny of billions of dollars in pandemic relief funds for healthcare provider groups in 2023 and beyond, as described in the Healthcare Fraud & Abuse Review 2022 published today by Bass, Berry & Sims.
- NASHVILLE, Tenn., Feb. 13, 2023 /PRNewswire-PRWeb/ -- In 2022, the federal government set the stage for wider scrutiny of billions of dollars in pandemic relief funds for healthcare provider groups in 2023 and beyond, as described in the Healthcare Fraud & Abuse Review 2022 published today by Bass, Berry & Sims .
- "We expect that this is the beginning of a years-long effort to pursue cases concerning provider relief funds that may involve far more complex circumstances than the blatant fraud that DOJ has prosecuted so far.
- We also expect whistleblowers to target alleged fraud in use of COVID-19 relief funds in qui tam cases filed under the False Claims Act."
- The Department of Justice's (DOJ) proactive focus on fraud in COVID-19 relief programs fits a pattern of more government-initiated healthcare fraud enforcement activity overall.